(Total Views: 153)
Posted On: 12/12/2017 9:22:42 PM
Post# of 2022
Been very busy lately with another real estate deal. The blessings continue to happen for me and for that I am very humble. With that said I will be buying more EVIO (flipping away)as this is without a doubt going to be a huge runner in the next year. EVIO has no cash and will not have a great Q4. However, they will have a unbelievable Q/Q comparison in Q1 and even better Q2. Yes they have diluted but when losing money it is a beech to get money. Getting this foothold is absolutely crucial. We were almost at a standstill waiting for this accreditation.
Many folks are clueless to the synergies being created and the ability to spread the costs with these deals. With a little DD take a good look at what this lab with ownership brings to the table. More services for each lab equaling more revenues. Yet SGA will remain the same. I do have an accounting degree and find it incredibly sad that people are not buying with all of the great news of late.
There is no public company in this space(lab testing) that has 1/2 of what EVIO has in place. I challenge anyone to show me a better investment within this industry with a true comparable.
Many folks are clueless to the synergies being created and the ability to spread the costs with these deals. With a little DD take a good look at what this lab with ownership brings to the table. More services for each lab equaling more revenues. Yet SGA will remain the same. I do have an accounting degree and find it incredibly sad that people are not buying with all of the great news of late.
There is no public company in this space(lab testing) that has 1/2 of what EVIO has in place. I challenge anyone to show me a better investment within this industry with a true comparable.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Scroll down for more posts ▼